Genelux Corporation Is A Publicly Traded Biopharmaceutical Company Based In Westlake Villagecaliforniafounded In 2001The Company Specializes In Developing Oncolytic Viral Immunotherapies To Treat Aggressive Solid Tumors That Are Challenging To Manage With Conventional Treatmentstheir Proprietary Choicea C Platform Supports The Creation Of A Diverse Library Of Immunotherapeutic Candidates The Lead Productolvi Vecis A Modified Strain Of The Vaccinia Virus Designed To Target Solid Tumorscurrently Undergoing A Pivotal Phase 3 Clinical Trial For Platinum Resistant Ovarian Canceradditionallygenelux Is Developing V2Act Immunotherapy For Pancreatic Cancer And Has A Clinical Stage Productv Vet1Aimed At Veterinary Therapeuticsgenelux Focuses On Addressing The Needs Of Patients With Difficult To Treat Cancersworking Closely With Healthcare Providers And Oncologists
No conferences found for this company.
| Company Name | Genelux Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
